Security Snapshot

Fortress Biotech, Inc. - Common Stock, par value $0.0001 per share (FBIO) Institutional Ownership

CUSIP: 34960Q109

13F Institutional Holders and Ownership History from Q1 2015 to Q2 2024

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

n/a

Price

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Symbol
FBIO on Nasdaq
Shares outstanding
35,059,667
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • FBIO - Fortress Biotech, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 34960Q109.
  • 13F reference-period holder data is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder data for the Q2 2026 reference period is not available.
  • Available periods remain in the history table; they do not substitute for the headline period.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

34960Q109

13F reference period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

FBIO full holder history Fortress Biotech, Inc. SEC filings Fortress Biotech, Inc. company facts Fortress Biotech, Inc. insider transactions Fortress Biotech, Inc. 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
FBIO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.8% 2,734,654 Highbridge Capital Management, LLC 31 Mar 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
38
Headline period
n/a
Rows shown
1-25 of 38
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$42,006 0
2024 Q1 144,700 $42,006 +$42,006 $0.29 1
2023 Q4 0 $0 -$5,746,547 0
2023 Q3 19,809,063 $5,749,187 -$2,025,532 $0.29 43
2023 Q2 24,149,052 $13,278,866 -$3,435,262 $0.55 46
2023 Q1 28,425,069 $23,306,552 +$426,105 $0.82 51
2022 Q4 27,497,866 $18,009,174 -$2,026,397 $0.66 47
2022 Q3 29,999,838 $25,794,770 -$780,486 $0.86 56
2022 Q2 30,820,541 $25,882,668 -$4,832,922 $0.84 60
2022 Q1 35,590,426 $48,404,672 +$4,121,988 $1.36 77
2021 Q4 31,748,690 $79,363,187 +$4,365,775 $2.50 78
2021 Q3 30,257,618 $97,454,567 +$678,828 $3.22 76
2021 Q2 30,005,418 $107,116,199 -$4,495,832 $3.57 81
2021 Q1 31,269,164 $110,368,273 -$2,163,672 $3.53 81
2020 Q4 31,890,183 $101,129,398 +$3,026,700 $3.17 84
2020 Q3 26,981,923 $108,992,555 +$32,990,008 $4.04 75
2020 Q2 22,594,538 $60,554,070 +$36,623,387 $2.68 72
2020 Q1 9,185,993 $17,362,233 +$4,224,635 $1.89 53
2019 Q4 6,851,537 $17,601,676 +$2,462,168 $2.57 51
2019 Q3 6,597,888 $9,303,785 +$551,462 $1.41 47
2019 Q2 6,173,403 $9,260,643 -$717,092 $1.50 43
2019 Q1 6,540,627 $11,626,335 -$599,189 $1.78 45
2018 Q4 7,101,953 $6,106,878 -$1,704,990 $0.86 52
2018 Q3 8,435,451 $13,710,475 +$747,616 $1.60 60
2018 Q2 7,590,340 $22,619,672 +$1,930,311 $2.98 60
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .